AKBA
Akebia Therapeutics, Inc.$1.43+0.01 (+0.35%)Prev Close$1.42·MCap$383.1M·P/E—·Vol1.16M·Yield—
▲
Buys (12M)
1
$86.6K
▼
Sells (12M)
9
$1.16M
◆
Net Activity
Net Seller
$1.07M
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at Akebia Therapeutics, Inc. (AKBA) has been dominated by selling, with 1 insider purchase totaling $86.6K and 9 insider sales totaling $1.16M. The most recent insider transaction was by Butler John P. (director, officer: CEO and President), who purchased $86.6K worth of shares on Mar 5, 2026. Akebia Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $383.1M.
AKBA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Butler John P. | director, officer: CEO and President | Buy | 69,270 | $1.25 | $86.6K | 3,367,064 |
| Feb 2, 2026 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 67,658 | $1.39 | $94.0K | 0 |
| Feb 2, 2026 | Butler John P. | CEO and President | Sell | 341,305 | $1.39 | $474.4K | 0 |
| Feb 2, 2026 | Grund Nicholas | Chief Commercial Officer | Sell | 84,829 | $1.39 | $117.9K | 0 |
| Feb 2, 2026 | Malabre Richard C | SVP, Chief Accounting Officer | Sell | 49,524 | $1.39 | $68.8K | 0 |
| Feb 2, 2026 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | Sell | 34,951 | $1.39 | $48.6K | 0 |
| Feb 2, 2026 | Rucci Carolyn M. | SVP, Chief Legal Officer | Sell | 69,772 | $1.39 | $97.0K | 0 |
| Jun 30, 2025 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | Sell | 41,314 | $3.67 | $151.6K | 0 |
| Jun 9, 2025 | Malabre Richard C | SVP, Chief Accounting Officer | Sell | 15,000 | $4.01 | $60.1K | 0 |
| Jun 4, 2025 | Malabre Richard C | SVP, Chief Accounting Officer | Sell | 13,334 | $3.53 | $47.1K | 0 |
| Mar 3, 2025 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 7,144 | $1.83 | $13.1K | 0 |
| Mar 3, 2025 | Butler John P. | CEO and President | Sell | 46,409 | $1.83 | $84.9K | 0 |
| Jan 31, 2025 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 50,506 | $2.10 | $106.1K | 0 |
| Jan 31, 2025 | Butler John P. | CEO and President | Sell | 144,250 | $2.10 | $302.9K | 0 |
| Jan 31, 2025 | Grund Nicholas | Chief Commercial Officer | Sell | 55,621 | $2.10 | $116.8K | 0 |
| Jan 31, 2025 | Malabre Richard C | SVP, Chief Accounting Officer | Sell | 30,202 | $2.10 | $63.4K | 0 |
| May 13, 2024 | Dahan Michel | SVP, Chief Operating Officer | Sell | 34,840 | $1.26 | $43.9K | 0 |
| May 13, 2024 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 12,016 | $1.26 | $15.1K | 0 |
| Feb 29, 2024 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 7,169 | $1.58 | $11.3K | 0 |
| Feb 29, 2024 | Butler John P. | CEO and President | Sell | 46,570 | $1.58 | $73.6K | 0 |
| Feb 29, 2024 | Dahan Michel | SVP, Chief Operating Officer | Sell | 8,661 | $1.58 | $13.7K | 0 |
| Feb 29, 2024 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 5,974 | $1.58 | $9.4K | 0 |
| Feb 27, 2024 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 8,367 | $1.52 | $12.7K | 0 |
| Feb 27, 2024 | Butler John P. | CEO and President | Sell | 37,733 | $1.52 | $57.4K | 0 |
| Feb 27, 2024 | Dahan Michel | SVP, Chief Operating Officer | Sell | 10,744 | $1.52 | $16.3K | 0 |
| Feb 27, 2024 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 7,411 | $1.52 | $11.3K | 0 |
| Jan 31, 2024 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 24,311 | $1.68 | $40.8K | 0 |
| Jan 31, 2024 | Butler John P. | CEO and President | Sell | 46,489 | $1.68 | $78.1K | 0 |
| Aug 25, 2023 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 27,000 | $1.15 | $31.1K | 0 |
| May 24, 2023 | Dahan Michel | SVP, Chief Operating Officer | Sell | 95,478 | $1.22 | $116.8K | 0 |
| May 24, 2023 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 63,186 | $1.22 | $77.3K | 0 |
| May 16, 2023 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 63,567 | $1.07 | $67.9K | 0 |
| Mar 1, 2023 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 7,510 | $0.88 | $6.6K | 0 |
| Mar 1, 2023 | Butler John P. | CEO and President | Sell | 91,868 | $0.88 | $80.6K | 0 |
| Mar 1, 2023 | Dahan Michel | SVP, Chief Operating Officer | Sell | 20,412 | $0.88 | $17.9K | 0 |
| Mar 1, 2023 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 13,034 | $0.88 | $11.4K | 0 |
| Mar 1, 2023 | Spellman David A | SVP, CFO and Treasurer | Sell | 810 | $0.88 | $710.77 | 0 |
| Feb 27, 2023 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 7,539 | $0.81 | $6.1K | 0 |
| Feb 27, 2023 | Butler John P. | CEO and President | Sell | 38,632 | $0.81 | $31.4K | 0 |
| Feb 27, 2023 | Dahan Michel | SVP, Chief Operating Officer | Sell | 10,090 | $0.81 | $8.2K | 0 |
| Feb 27, 2023 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 6,677 | $0.81 | $5.4K | 0 |
| Aug 31, 2022 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 1,147 | $0.36 | $415.79 | 0 |
| Jun 3, 2022 | GILMAN STEVEN C | Director | Sell | 4,567 | $0.36 | $1.7K | 0 |
| Feb 28, 2022 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 15,056 | $2.16 | $32.6K | 0 |
| Feb 28, 2022 | Cotreau Violetta | SVP, Chief Accounting Officer | Sell | 3,946 | $2.15 | $8.5K | 0 |
| Feb 28, 2022 | Dahan Michel | SVP, Chief Operating Officer | Sell | 14,660 | $2.16 | $31.7K | 0 |
| Feb 28, 2022 | Faulkingham Dell | SVP, CCO | Sell | 13,184 | $2.16 | $28.5K | 0 |
| Feb 28, 2022 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 1,078 | $2.17 | $2.3K | 0 |
| Feb 28, 2022 | Spellman David A | SVP, CFO and Treasurer | Sell | 803 | $2.17 | $1.7K | 0 |
| Jan 3, 2022 | Cotreau Violetta | SVP, Chief Accounting Officer | Sell | 5,833 | $2.29 | $13.3K | 0 |
Showing 1–50 of 62
1 / 2
AKBA Insider Buying Activity
The following table shows recent insider purchases of Akebia Therapeutics, Inc. (AKBA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Butler John P. | director, officer: CEO and President | Buy | 69,270 | $1.25 | $86.6K | 3,367,064 |
AKBA Insider Selling Activity
The following table shows recent insider sales of Akebia Therapeutics, Inc. (AKBA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 67,658 | $1.39 | $94.0K | 0 |
| Feb 2, 2026 | Butler John P. | CEO and President | Sell | 341,305 | $1.39 | $474.4K | 0 |
| Feb 2, 2026 | Grund Nicholas | Chief Commercial Officer | Sell | 84,829 | $1.39 | $117.9K | 0 |
| Feb 2, 2026 | Malabre Richard C | SVP, Chief Accounting Officer | Sell | 49,524 | $1.39 | $68.8K | 0 |
| Feb 2, 2026 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | Sell | 34,951 | $1.39 | $48.6K | 0 |
| Feb 2, 2026 | Rucci Carolyn M. | SVP, Chief Legal Officer | Sell | 69,772 | $1.39 | $97.0K | 0 |
| Jun 30, 2025 | Ostrowski Erik | SVP, CFO, CBO & Treasurer | Sell | 41,314 | $3.67 | $151.6K | 0 |
| Jun 9, 2025 | Malabre Richard C | SVP, Chief Accounting Officer | Sell | 15,000 | $4.01 | $60.1K | 0 |
| Jun 4, 2025 | Malabre Richard C | SVP, Chief Accounting Officer | Sell | 13,334 | $3.53 | $47.1K | 0 |
| Mar 3, 2025 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 7,144 | $1.83 | $13.1K | 0 |
| Mar 3, 2025 | Butler John P. | CEO and President | Sell | 46,409 | $1.83 | $84.9K | 0 |
| Jan 31, 2025 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 50,506 | $2.10 | $106.1K | 0 |
| Jan 31, 2025 | Butler John P. | CEO and President | Sell | 144,250 | $2.10 | $302.9K | 0 |
| Jan 31, 2025 | Grund Nicholas | Chief Commercial Officer | Sell | 55,621 | $2.10 | $116.8K | 0 |
| Jan 31, 2025 | Malabre Richard C | SVP, Chief Accounting Officer | Sell | 30,202 | $2.10 | $63.4K | 0 |
| May 13, 2024 | Dahan Michel | SVP, Chief Operating Officer | Sell | 34,840 | $1.26 | $43.9K | 0 |
| May 13, 2024 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 12,016 | $1.26 | $15.1K | 0 |
| Feb 29, 2024 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 7,169 | $1.58 | $11.3K | 0 |
| Feb 29, 2024 | Butler John P. | CEO and President | Sell | 46,570 | $1.58 | $73.6K | 0 |
| Feb 29, 2024 | Dahan Michel | SVP, Chief Operating Officer | Sell | 8,661 | $1.58 | $13.7K | 0 |
| Feb 29, 2024 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 5,974 | $1.58 | $9.4K | 0 |
| Feb 27, 2024 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 8,367 | $1.52 | $12.7K | 0 |
| Feb 27, 2024 | Butler John P. | CEO and President | Sell | 37,733 | $1.52 | $57.4K | 0 |
| Feb 27, 2024 | Dahan Michel | SVP, Chief Operating Officer | Sell | 10,744 | $1.52 | $16.3K | 0 |
| Feb 27, 2024 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 7,411 | $1.52 | $11.3K | 0 |
| Jan 31, 2024 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 24,311 | $1.68 | $40.8K | 0 |
| Jan 31, 2024 | Butler John P. | CEO and President | Sell | 46,489 | $1.68 | $78.1K | 0 |
| Aug 25, 2023 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 27,000 | $1.15 | $31.1K | 0 |
| May 24, 2023 | Dahan Michel | SVP, Chief Operating Officer | Sell | 95,478 | $1.22 | $116.8K | 0 |
| May 24, 2023 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 63,186 | $1.22 | $77.3K | 0 |
| May 16, 2023 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 63,567 | $1.07 | $67.9K | 0 |
| Mar 1, 2023 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 7,510 | $0.88 | $6.6K | 0 |
| Mar 1, 2023 | Butler John P. | CEO and President | Sell | 91,868 | $0.88 | $80.6K | 0 |
| Mar 1, 2023 | Dahan Michel | SVP, Chief Operating Officer | Sell | 20,412 | $0.88 | $17.9K | 0 |
| Mar 1, 2023 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 13,034 | $0.88 | $11.4K | 0 |
| Mar 1, 2023 | Spellman David A | SVP, CFO and Treasurer | Sell | 810 | $0.88 | $710.77 | 0 |
| Feb 27, 2023 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 7,539 | $0.81 | $6.1K | 0 |
| Feb 27, 2023 | Butler John P. | CEO and President | Sell | 38,632 | $0.81 | $31.4K | 0 |
| Feb 27, 2023 | Dahan Michel | SVP, Chief Operating Officer | Sell | 10,090 | $0.81 | $8.2K | 0 |
| Feb 27, 2023 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 6,677 | $0.81 | $5.4K | 0 |
| Aug 31, 2022 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 1,147 | $0.36 | $415.79 | 0 |
| Jun 3, 2022 | GILMAN STEVEN C | Director | Sell | 4,567 | $0.36 | $1.7K | 0 |
| Feb 28, 2022 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 15,056 | $2.16 | $32.6K | 0 |
| Feb 28, 2022 | Cotreau Violetta | SVP, Chief Accounting Officer | Sell | 3,946 | $2.15 | $8.5K | 0 |
| Feb 28, 2022 | Dahan Michel | SVP, Chief Operating Officer | Sell | 14,660 | $2.16 | $31.7K | 0 |
| Feb 28, 2022 | Faulkingham Dell | SVP, CCO | Sell | 13,184 | $2.16 | $28.5K | 0 |
| Feb 28, 2022 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 1,078 | $2.17 | $2.3K | 0 |
| Feb 28, 2022 | Spellman David A | SVP, CFO and Treasurer | Sell | 803 | $2.17 | $1.7K | 0 |
| Jan 3, 2022 | Cotreau Violetta | SVP, Chief Accounting Officer | Sell | 5,833 | $2.29 | $13.3K | 0 |
AKBA Insiders
Butler John P.
director, officer: CEO and President
Bought $86.6KSold $1.37M
11 tradesLast: Mar 5, 2026
Similar Stocks to AKBA
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B